Vaccinia-Related Kinase 1 Is Required for the Maintenance of Undifferentiated Spermatogonia in Mouse Male Germ Cells by Choi, Yoon Ha et al.
Vaccinia-Related Kinase 1 Is Required for the
Maintenance of Undifferentiated Spermatogonia in
Mouse Male Germ Cells
Yoon Ha Choi
1, Choon-Ho Park
1, Wanil Kim
1, Hua Ling
2, Aram Kang
2, Matthew Wook Chang
2,
Sun-Kyoung Im
1, Hyun-Woo Jeong
1, Young-Yun Kong
3, Kyong-Tai Kim
1,4*
1Division of Molecular and Life Science, Department of Life Science, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea, 2School of
Chemical and Biomedical Engineering, Nanyang Technological University, Singapore, Singapore, 3Department of Biological Sciences, Seoul National University, Seoul,
Republic of Korea, 4Division of Integrative Bioscience and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea
Abstract
Vaccinia-related kinase 1 (VRK1) is a crucial protein kinase for mitotic regulation. VRK1 is known to play a role in germ cell
development, and its deficiency results in sterility. Here we describe that VRK1 is essential for the maintenance of
spermatogonial stem cells. To determine whether VRK1 plays a role in these cells, we assessed the population size of
undifferentiated spermatogonia. Flow cytometry analyses showed that the number of undifferentiated spermatogonia was
markedly reduced in VRK1-deficient testes. VRK1 was highly expressed in spermatogonial populations, and approximately
66% of undifferentiated spermatogonia that were sorted as an Ep-CAM
+/c-kit
2/alpha-6-integrin
+ population showed a
positive signal for VRK1. Undifferentiated stem cells expressing Plzf and Oct4 but not c-kit also expressed VRK1, suggesting
that VRK1 is an intrinsic factor for the maintenance of spermatogonial stem cells. Microarray analyses of the global testicular
transcriptome and quantitative RT-PCR of VRK1-deficient testes revealed significantly reduced expression levels of
undifferentiated spermatogonial marker genes in early postnatal mice. Together, these results suggest that VRK1 is required
for the proliferation and differentiation of undifferentiated spermatogonia, which are essential for spermatogenic cell
maintenance.
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Introduction
Spermatogenesis is a highly productive and tightly regulated
process. Multiple cell types, including somatic and germ cells, play
different roles to maintain continuous sperm cell production. To
sustain the germ cell population, the active proliferation of
spermatogonia is required. Moreover, the proliferation rate, which
is one of the highest in the body, must be well regulated.
Spermatogonial stem cells (SSCs) are adult stem cells in the testes
that support the germ cell pool throughout a male’s life. Like other
stem cells, SSCs can self-renew and differentiate into spermatozoa.
These stem cells can proliferate rapidly to restore the germ cell
population if that population becomes diminished (e.g., following
exposure to a toxic chemical agent or irradiation). However, under
normalphysiological conditions, these cellsdivideslowlyto generate
bothstemcellsand progenitorcells[1].Unidentifiedsubpopulations
of undifferentiated spermatogonia have stem cell capabilities.
Undifferentiated spermatogonia comprise Asingle (As), Apaired (Apr),
and Aaligned (Aal) cells among type A spermatogonia [2,3,4].
Vaccinia-related kinases (VRKs) belong to the casein kinase
family whose catalytic domain shares homology with the vaccinia
virus gene, B1R [5]. Mammalian genomes encode three types of
VRK proteins, namely VRK1, VRK2, and VRK3. VRK1 and
VRK3 possess C- and N-terminal nuclear localization signals,
respectively, while VRK2 has a C-terminal transmembrane
domain. Interestingly, while VRK1 and VRK2 are enzymatically
active, VRK3 is claimed as a pseudokinase whose substrates have
not yet been identified [6]. VRK1 is highly expressed in both
actively proliferating tissues, human tumor cell lines, and several
tumor tissues suggesting that it plays an important role in cell cycle
progression [5,7,8]. Recent studies have revealed several possible
mechanisms by which VRK1 controls cell cycle progression. We
have shown that VRK1 phosphorylates histone H3 on Thr3 and
Ser10 during mitosis. Phosphorylation of the above residues is
involved in important mitotic signals that induce chromatin
condensation [9]. In addition, VRK1 is known to phosphorylate
barrier-to-autointegration factor (BAF), which is critical for
supporting both the nuclear envelope and chromatin structure.
VRK1-mediated phosphorylation of BAF triggers BAF release from
nuclear membrane proteins that contain LEM domains, causing
disintegration of the nuclear envelope during early mitosis [10].
Furthermore, VRK1 expression is necessary for cyclin D1
expression and G1 progression [11,12]. Mechanistically this is due
to the incorporation of VRK1 to the cyclin D1 gene transcription
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binding protein in Ser133, which is important for cyclin D1
induction [12]. Finally, VRK1 has also been known to phosphor-
ylate several transcription factors, such as p53 [13,14], ATF2 [15],
and c-Jun [16], to increase transcription factor stability and activity.
Recently, many researchers have made an effort to examine the
genetics of VRK1 in various organisms. A VRK1 gene-depleted
mammalian model was first reported by Wiebe et al. [17]. A VRK1
gene deficiency gives rise to defects in gametogenesis, resulting in
infertility in both sexes. In male mice, hypomorphism of VRK1
leads to progressive germ cell loss caused by an impairment of
spermatogonial proliferation. VRK1 deficiency results in the
progressive loss of spermatogonia that exhibit GCNA
+ (germ cell
nuclear antigen) and PCNA
+ (proliferating cell nuclear antigen).
In this report, we also generated VRK1-deficient mice that have
a reporter construct in the Vrk1 intron region and asked whether a
VRK1 deficiency might affect the maintenance of spermatogonial
stem cells.To test ourhypothesis, wequantifiedstem cell population
in the testes of VRK1-deficient mice using flow cytometry. In
addition, we also analyzed the testicular transcriptome of VRK1-
deficient mice using DNA microarray and quantitative RT-PCR to
investigate gene expression changes of specific markers during the
first wave of spermatogenesis in postnatal mice. Here we present
evidence to suggest that VRK1 is essential for the proper
maintenance of undifferentiated spermatogonia.
Results
Expression patterns of VRK1 in germ cell populations
For the genetic analysis of VRK1 in mice, we used VRK1-
deficient mice as previously reported (Figure S1) [17]. This mouse
contains a b-geo insertion in intron 3 of VRK1, as a result of the
expression of N-terminal 72 amino acids of VRK1 fused to b-geo.
As previous study revealed that this mouse is hypomorphic for
VRK1, we also confirmed some of full length VRK1 was
expressed in the homozygote (Figure S1) [17]. In the testis, it
was confirmed that VRK1 messenger RNA was localized to the
periphery of seminiferous tubules in wild-type testis but was absent
centrally (Figure 1A). Histological examination of the testes from
heterozygote with the b-galactosidase substrate X-gal (5-bromo-4-
chloro-3-indolyl-b-D-galactoside) showed that VRK1 expression
was restricted to the seminiferous tubules and was confined within
the first layer of cells adjacent to the basement membrane.
Therefore, we confirmed that the Vrk1 gene is successfully trapped
Figure 1. Expression of VRK1 in spermatogonial cells. (A) In situ hybridization with sense (S) or antisense (AS) probes against VRK1 mRNA (red).
All testicular cells were counterstained with Hoechst 33342 (blue). (B) A section of testis from a heterozygous mouse was stained for b-galactosidase
(blue) and counterstained with eosin (pink). Positive blue staining specifies the spermatogonia. He: heterozygote testis, WT: wild type testis. (C)
Immunohistochemisty using a polyclonal antibody against VRK1 on a cross-section of testes isolated from an adult wild type mouse. Arrowheads and
arrows in the lower panels indicate localization of Sertoli and spermatogonia, each. (D) Flow cytometry on freshly dissociated adult germ cells from a
heterozygote that were positively or negatively sorted with Ep-CAM antibody. Cells were stained with FDG to identify VRK1-expressing cells.
doi:10.1371/journal.pone.0015254.g001
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(Figure 1B).
According to a previous report, VRK1 is expressed in spermato-
gonia and Sertoli cells [17]. But, to date, the localization of VRK1 in
mouse organs has not been confirmed with a VRK1-specific
antibody. We generated anti-mouse VRK1 antibody from rabbits
for further research, and its specificity was verified by Western blot
analysis(Figure S2). Fifty microgramsof nucleus extracts from several
organs were loaded onto an SDS/PAGE gel, and VRK1 was
detected. The band of mouse VRK1 (51 kDa) was detected in
thymus, spleen, and testis of wild type mice, but we could not detect
any signal from the above-mentioned tissues in VRK1-deficient mice
(Figure S2). According to a previous report, transcripts from VRK1
deficient mice were reduced by 80–85% compared with wild type
[17]. Therefore, VRK1 protein appeared too low to detect with anti-
VRK1 antibody in VRK1-deficient mice.
To test anti-VRK1 antibodies in mouse tissues, we examined
testis samples from wild-type mice. VRK1 was expressed along the
basal layer of the testis in which A and B type spermatogonia were
aligned (Figure 1C). Although VRK1 was expressed in spermato-
gonia (Figure 1C, indicated by arrows), in contrast to previous
report, we could not detect VRK1 protein in Sertoli cells by
immunohistochemistry (Figure 1C, indicated by arrowheads)[17].
We also assessed the expression levels of VRK1 in spermatogonial
populations using flow cytometry. To quantify the expression
levels of VRK1 in spermatogonia, cells from VRK1-deficient mice
were stained with fluorescein di-D-galactopyranoside (FDG), a
substrate for b-galactosidase. As a result, the cells labeled with Ep-
CAM were positive for fluorescein. These results indicated that
spermatogonia specifically express VRK1 (Figure 1D).
Defects in cell cycle progression in spermatogonia of
VRK1- deficient early postnatal mice
As degeneration of testes can be induced by a spermatogonial
proliferation defect, we assessed proliferating spermatogonia in
VRK1-deficient testes by immunostaining for cyclin D1, a marker
of mitotically active spermatogonia (Figure 2B). Although we
observed no obvious degeneration of tubules at an early age
(Figure 2A), the number of proliferating spermatogonia began to
decrease within 2 weeks (Figure 2B).
To assess the effects of VRK1 deficiency on spermatogenesis in
detail, we analyzed gene expression levels in the testis by
microarray (Table 1). Testicular cells of pups (day 8) were
subjected to analysis; at this age, spermatogonia actively proliferate
Figure 2. Defects in spermatogonia caused by aberrant cell proliferation in VRK1-deficient testes. (A) Histology of testes from 1-week-
old VRK1-deficient. Testes from wild type and VRK1-deficient mice were stained with hematoxylin and eosin. Scale bar, 200 mm. (B)
Immunohistochemistry with anti-cyclin D1 antibody for wild type testes (n=3) and VRK1-deficient (n=3) mice at 1 week and 2 weeks of age.
Scale bar, 200 mm. More than 30 tubules were scored for each genotype. The mean value is shown with the standard error.
doi:10.1371/journal.pone.0015254.g002
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genes related to spermatogenesis were disrupted; particularly,
spermatogonia-specific transcripts (Lin28, Stra8, Dazl, Ep-CAM,
and Crabp1) were downregulated. Lin28, a pluripotency factor, is
expressed in pluripotent cells and undifferentiated spermatogonia
[19]. Although genes expressed in undifferentiated spermatogonia
were not abundantly detected by microarray analysis, we
identified that several marker genes in undifferentiated spermato-
gonia, including Plzf, Pou3f1, Pou5f1, Ret and Ngn3 were
significantly reduced by qRT-PCR (Figure 3A). Because undiffer-
entiated spermatogonia were present at a low concentration, these
genes could not be detected by microarray analysis. We confirmed
the differential expression of select genes by qRT-PCR and
showed an overall concordance of relative expression levels with
those obtained by microarray analysis (Figure 3A and 3B). This
finding indicates that VRK1 plays a critical role in the
maintenance of spermatogonia during an early postnatal age.
Altered genes were classified into functional categories using
Gene Ontology (GO) (Table S2). We found some genes that are
able to globally influence spermatogenesis (Table 1 and Figure 3B).
VRK1 deficiency caused a reduction in Bmp8 (bone morphoge-
netic protein 8) expression levels. Bmp8a and b are ubiquitously
expressed in spermatogonia and primary spermatocytes before 3.5
weeks of age. Bmp8 absence results in an impairment of germ cell
proliferation and differentiation [20,21]. Glial cell line-derived
neurotrophic factor (GDNF) is produced by Sertoli cells and
controls the maintenance of germ line stem cells. Loss of germ cells
caused by drug treatment and cryptorchid procedures results in an
increase in GDNF expression [22,23]. Interestingly, GDNF gene
expression increased in VRK1-deficient testes, perhaps to repair
impaired spermatogonial function. We also found that the
expression levels of several genes in the meiosis category were
perturbed, indicating a functional impairment of VRK1 during
the first wave of the spermatogenesis.
Expression levels of VRK1 in undifferentiated
spermatogonia
Several factors influence the cell cycle progression of undiffer-
entiated spermatogonia, including hormones, growth factors,
Sertoli cells, and other germ cells. Because of the progressive
degeneration and agametic phenotype of VRK1-deficient testes,
we investigated whether VRK1 directly influences the function of
undifferentiated spermatogonia in a cell-autonomous manner. To
determine whether VRK1 is expressed in undifferentiated
spermatogonia, we performed immunocytochemistry with Ep-
CAM-positive spermatogonial cells sorted by MACS. We found
that undifferentiated spermatogonia expressing Oct-4 and Plzf also
expressed VRK1 (Figure 4A and 4B). C-kit has been detected in a
broad range of type A and differentiated spermatogonia [24,25];
undifferentiated spermatogonia lacking c-kit appeared to express
VRK1 (Figure 4C, indicated by arrow). Within c-kit-positive
spermatogonia, there were separate populations that either
expressed VRK1 or not, meaning that VRK1 is not expressed
in all differentiated spermatogonial populations (Figure 4D,
indicated by arrowhead and asterisk).
To further confirm VRK1 expression levels in undifferentiated
spermatogonia, we also quantified VRK1 expression levels by flow
cytometry (Figure 4E). Spermatogonia were stained with Ep-CAM
antibody and sorted by MACS. Cells expressing VRK1 were
stained with fluorescein processed by FDG. To identify undiffer-
entiated spermatogonial populations, cells were labeled with anti-
a6-integrin and c-kit antibody [25]. As a result, nearly 66% of cells
that were a6-integrin
+ and c-kit
2 expressed VRK1 (Figure 4E). As
the data demonstrate, cells expressing makers for undifferentiated
spermatogonia also expressed VRK1, suggesting that the defect in
VRK1-deficient testes might be inherent for undifferentiated
spermatogonia.
Table 1. Microarray-based transcriptome analysis of testicular
cells in adult wild type and VRK1-deficient mice.
Spermatogonia p-value Fold change Regulation
Stra8 0.031 2.79 Down
Dazl 0.031 2.03 Down
Tacstd1 (Ep-CAM) 0.042 2.18 Down
Crabp1 0.034 2.51 Down
Lin28a 0.010 2.17 Down
Lin28b 0.002 2.85 Down
Meiosis p-value Fold change Regulation
Ovol1 0.014 2.93 Down
Ccnb3 0.006 4.13 Down
Cpeb1 0.003 2.51 Down
Mei1 0.010 3.67 Down
Ccna1 0.037 2.07 Down
Sycp2 0.004 3.17 Down
Syce1 0.020 2.37 Down
Boll 0.018 2.36 Down
Smc1b 0.033 2.22 Down
Stag3 0.004 2.04 Down
Msh4 0.050 2.13 Down
Clgn 0.037 2.05 Down
Suv39h2 0.036 2.03 Down
Spermatogenesis p-value Fold change Regulation
Tssk3 0.012 2.77 Down
Rnf17 0.023 2.26 Down
Mov10l1 0.017 2.25 Down
Ovol1 0.014 2.93 Down
Prok2 0.014 4.85 Down
Gal3st1 0.034 3.97 Down
Bmp8a 0.006 2.06 Down
Bmp8b 0.007 3.08 Down
Mtl5 0.013 2.43 Down
Dazl 0.031 2.03 Down
Spag16 0.004 3.35 Down
Ccna1 0.037 2.07 Down
Hmga1 0.018 2.06 Down
Boll 0.018 2.36 Down
Nlrp14 0.010 2.80 Down
Msh4 0.050 2.13 Down
Clgn 0.037 2.05 Down
Hsf2bp 0.002 3.53 Down
Dnmt3a 0.010 2.04 Down
Jag2 0.006 2.45 Down
Gdnf 0.027 2.25 Up
Differently expressed genes involved in spermatogonia, meiosis, and
spermatogenesis in VRK1-deficient testes were listed.
doi:10.1371/journal.pone.0015254.t001
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in VRK1-deficient
2 mice
We postulated that the gradual depletion of germ cells in aging
VRK1-deficient mice was accelerated by dysfunctional undiffer-
entiated spermatogonia. To examine this hypothesis, we also used
flow cytometry to study the proportional change in undifferenti-
ated spermatogonia in cells harvested from VRK1-deficient mice.
The method published by Takubo et al. and Kubota et al. was
used with few modifications to isolate undifferentiated spermato-
gonia [26,27]. In purified spermatogonia, cells with high forward
light scatter and low side-angle light scatter values [25] were first
gated by c-kit expression and then by a6-integrin and Thy1.2
expression. The undifferentiated spermatogonial population,
defined as c-kit
2, a6-integrin
+, and Thy1.2
+, was reduced slightly
in 2-week-old VRK1-deficient mice (Figure 5A). This change was
further pronounced in 8-week-old mice as undifferentiated
spermatogonial cell fractions constituted only 0.17% of the testis
cell population. In wild-type testes, these cells composed 0.9% of
the population (Figure 5B). Together, these data support the
hypothesis that VRK1 deficiency in mouse testes disrupts
undifferentiated spermatogonia, leading to a decrease in this cell
population.
Defects in the proliferation of undifferentiated
spermatogonia in VRK1-deficient mice
To further analyze the impairment of undifferentiated sper-
matogonia by VRK1 deficiency, we performed immunostaining of
seminiferous tubules with anti-Plzf antibody (Figure 6A and 6B).
Plzf is expressed in undifferentiated spermatogonia, that is, in As,
Apr, and Aal [28,29]. In seminiferous tubules from 5-week-old,
wild-type mice, the proportion of As and Apr were observed with
28.75% and 26.25% frequencies. Compared to wild type, the
proportion of each clustered cell type showed significant changes
in VRK1-deficient mice. As cells account for more than 50 percent
of the population in VRK1-deficient seminiferous tubules.
Whereas As and Apr were present in 70% of the counted clusters,
long-chain undifferentiated spermatogonia were present at lower
proportions than wild type. Moreover, Plzf-positive germ cells
were seldom detected in seminiferous tubules of 9-week-old mice
VRK1-deficient mice, similar to flow cytometry results (Figure 5B
and Figure S3). The chain lengths of the remaining undifferen-
tiated spermatogonia were generally short (Figure S3) in VRK1-
deficient seminiferous tubules. Type A spermatogonia underwent
a series of mitotic divisions into Apr,A al(4),A al(8), and Aal(16) cells
[3]. With these data, we hypothesized that the VRK1 deficiency
affects the mitotic division of undifferentiated spermatogonia,
resulting in their apparent loss.
Discussion
This study investigated the functional importance of VRK1 for
the maintenance of mammalian spermatogonial stem cells. In view
of current genetics analyses, VRK1 is important to the process of
gametogenesis. Previous reports have analyzed the function of
VRK in Caenorhabditis elegans and Drosophila melanogaster in which
single VRK orthologs exist. siRNA-mediated VRK depletion in C.
elegans results in early embryonic lethality caused by cell cycle
arrest during the earliest cell division [30]. In vrk-1 mutants of C.
elegans that express truncated VRK-1 proteins, sterility was
observed from defects in the cell cycle [31,32]. NHK1, the
VRK1 homolog in D. melanogaster, is important for karyosome
formation and metaphase arrest during meiosis. Mutations in
NHK1 lead to sterility in both male and female flies due to
abnormal meiotic spindle formation [33]. NHK1 mutations in
oocytes also cause the formation of multiple spindles and increased
chromosome condensation during prophase [34]. These reports
indicate that VRK1 plays an important role in germ cell
development. In contrast to C. elegans and D. melanogaster,
mammalian genomes encode three forms of VRK whose functions
are more diverse and complex. Among the VRK families, a
hypomorphic mouse model for VRK1 has been recently reported
[17]. VRK1 mutant mice generated by the gene trap method
showed progressive germ cell loss and resulting infertility. Germ
Figure 3. Impaired expression of genes involved in spermatogenesis at an early postnatal age. (A, B) DNA microarray and quantitative
RT-PCR analysis of spermatogonial marker genes (A) or spermatogenic genes (B) in total testicular cells from postnatal day 8 of wild-type and VRK1-
deficient mice. Each value of qRT-PCR was normalized to b-actin expression levels and expressed as the fold change relative to the levels detected in
wild type samples, which were set equal to 1. Error bars represent the mean 6 SD. Primers for qRT-PCR were presented in Table S1. W: wild type
testes, D: VRK1-deficient testes.
doi:10.1371/journal.pone.0015254.g003
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(PCNA), and c-kit-positive germ cells were all greatly reduced in
VRK1-deficient seminiferous tubules. Whereas adult mice showed
obvious germ cell defects, testes from prepubertal mice seemed
normal. The authors concluded that VRK1 deficiency did not
affect the maintenance of spermatogonial stem cells. This
conclusion was suggested by counting the number of Plzf-positive
cells in the seminiferous tubules during the first wave of
spermatogenesis. Previous studies also reported that mice in which
essential genes related to the maintenance of spermatogonial stem
Figure 4. Expression of VRK1 in undifferentiated spermatogonia. (A, B) Immunocytochemistry of spermatogonia sorted by Ep-CAM antibody
with VRK1 and Oct-4 (A) or Plzf (B). (C, D) Spermatogonia were stained with VRK1 and c-kit, and spermatogonia expressing VRK1 were negatively
stained with c-kit (C). Heterogeneous populations stained with VRK1 were shown in c-kit-positive spermatogonia (D). (E) Flow cytometry analysis of
VRK1-expressing spermatogonia that were then gated by c-kit
2 and a6-integrin
+ in the isolated Ep-CAM
+ fraction of heterozygous spermatogonia.
Cells were freshly stained with FDG.
doi:10.1371/journal.pone.0015254.g004
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in germ cell production during the first wave of spermatogenesis.
Few factors other than Plzf [28,29] and TATA box-binding
protein-associated factor 4b (Taf4b) [35] are known to be essential
for the maintenance of spermatogonial stem cells. Disruption of
the transcriptional repressor Plzf in mice results in a progressive
depletion of germ cells, resulting in a phenotype that consists only
of Sertoli cells. Similarly, inactivation of Taf4b results in severe
germ cell depletion characterized by tubules of only Sertoli cells
and male infertility [35]. Although these mice can complete
spermatogenesis, leading to the production of normal sperm
during the first wave of spermatogenesis, the number of germ cells
is reduced, and spermatogonial proliferation is defective at an
early age. All of these effects cause infertility in these animals.
In the present research, we analyzed the first wave of
spermatogenesis in VRK1-deficient mice and found that the
functional defect in spermatogenesis occurred at an early age.
Within 2 weeks, the number of actively proliferating spermatogo-
nia was significantly reduced as indicated by cyclin D1
immunostaining (Figure 2B). Moreover, the expression levels of
marker genes, including Plzf, POU5f1(Oct-4), POU3f1(Oct-6),
Ret, Ngn3, and Lin28, in undifferentiated spermatogonia were
markedly downregulated as indicated by microarray analysis and
quantitative RT-PCR by day 8 (Figure 3A). Therefore, these
results suggest that the impairment of important genes in
undifferentiated spermatogonia impede the normal meiotic
development of spermatocytes as shown by the GO data
(Table 1 and Table S1), indicating that VRK1 plays a crucial
role in normal spermatogenesis in neonatal mice.
First, we suppose that VRK1 may be involved in the
maintenance of spermatogonial stem cells because VRK1-
deficient testes have tubules containing cells at degenerated stages
of spermatogenesis or a Sertoli cell-only phenotype as previously
reported [17]. These phenotypes typically occur in testes
undergoing stem cell loss [3]. Wiebe et al. [13] also expected
that degeneration of germ cells is induced by the dysfunctional
division of differentiated spermatogonial cells, not by spermato-
gonial stem cells. However, we revealed that VRK1 deficiency
caused a loss of spermatogonial stem cells. We believe that this
discrepancy comes from the different methodologies for the
quantification of spermatogonial stem cells. Previous reports
counted the number of Plzf-positive cells in cross-sections of
seminiferous tubules. Although this examination can determine
the status of stem cells, it is ambiguous because analyses using
cross-sections cannot count all spermatogonial stem cells. Sper-
matogonial stem cells are a very rare population of all the germ
cells, and only a fraction of stem cells can be detected in cross-
sectioned tubules. Therefore, most studies quantify spermatogonial
stem cells by flow cytometry analysis with antibodies against
specific surface marker proteins, which enable the concentration of
spermatogonial stem cells for further functional analyses [3,26].
Our quantification results obtained by flow cytometry provide
evidence for the impairment of spermatogonial stem cells in
VRK1-deficient mice (Figure 5). Moreover, we found that in 5-
week-old VRK1 deficient testes, loss of chained undifferentiated
spermatogonia is apparent compared to wild type (Figure 5B). It
seems that the proliferation of undifferentiated spermatogonia
requires VRK1. Although it is unclear whether VRK1 directly
Figure 5. Loss of undifferentiated spermatogonia in VRK1-deficient testes. (A, B) Flow cytometric analysis of undifferentiated
spermatogonia, defined as c-kit
2, a6-integrin
+, and Thy1
+, in the isolated EpCAM
+ fraction in 2- (A) and 8- (B) week-old mice.
doi:10.1371/journal.pone.0015254.g005
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great reduction in the number of spermatogonial stem cells
appeared in VRK1-deficient mice. After 8 weeks, VRK1-deficient
testes showed a great reduction in spermatogonial stem cells by
flow cytometry analysis. In addition, Plzf-positive cells were rarely
detected after 9 weeks by whole mount immunohistochemisty of
seminiferous tubules (Figure S3). These results indicate that VRK1
is required for the maintenance of spermatogonial stem cells that
are regulated by self-renewal.
Spermatogonial stem cells can be regulated by both intrinsic
and extrinsic factors; therefore, we asked whether VRK1 directly
causes a loss of undifferentiated spermatogonia. Since it is
unknown which spermatogonial subpopulation expresses VRK1,
we confirmed the expression of VRK1 in undifferentiated
spermatogonia by immunocytochemistry after MACS and flow
cytometry analysis. We determined that undifferentiated sper-
matogonia expressing Oct-4 and Plzf but not c-kit also expressed
VRK1 (Figure 4). Among the undifferentiated spermatogonia
specified as Ep-CAM
+/a6-integrin
+/c-kit
2, approximately 66% of
cells expressed VRK1 (Figure 4E). These data suggest the
existence of a specific subpopulation in undifferentiated spermato-
gonia that expresses VRK1. Another possibility is that the level of
VRK1 changes during the phases of the cell cycle. As VRK1 is
highly expressed during the G2-M phases of the cell cycle in
somatic cells, the expression levels of VRK1 might also oscillate
during the cell cycle in proliferating spermatogonia. This idea
might contribute to the detection of undifferentiated spermatogo-
nia that are in the G2-M phase. Together, we suggest that VRK1
is a crucial intrinsic factor for the maintenance of spermatogonial
stem cells.
Here, we suggest VRK1 mainly exists in spermatogonia, but not
in Sertoli cells. VRK1 protein was detected in spermatogonia with
Figure 6. Loss of the chained undifferentiated spermatogonia in VRK1-deficient testes. (A) Five-week-old testes of wild-type and VRK1-
deficient mice were examined by whole-mount immunostaining with anti-Plzf antibody. Scale bars, 10 mm. (B) Frequency of the undifferentiated
spermatogonia clusters classified by the number of chains of cells. 160 (wild type) or 162 (VRK1-deficient testes) clusters that were clearly identified
were counted.
doi:10.1371/journal.pone.0015254.g006
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the previous study, GT12/GT12 (a gene-trap vector insertion
within intron 12 of Vrk1) tubule was stained with x-gal [17].
Although this data confirmed the promoter activity of VRK1in
spermatogonia and Sertoli cells, it does not determine whether
VRK1 protein exists or not. Proteolysis is a crucial mechanism for
the regulation of VRK1 [9]. But mutant VRK1 deleted in exon
13–15 may not be normally regulated because C-terminal region
of VRK1 has been suggested as a regulatory domain interacting
with other proteins [36]. Therefore, strong staining for beta-
galactosidase in Sertoli cells may be due to the accumulation of
mutant VRK1 protein.
Although VRK1 is not detected in Sertoli cells by immunohis-
tochemistry, undetectable amount of VRK1 protein might exist. In
this case, it cannot be overlooked that an impairment in the
maintenance of undifferentiated spermatogonia can be caused by a
malfunction of the stem cell niche supported by Sertoli cells. Wiebe
et al. showed that expression levels of the kit ligand were unaltered
in VRK1-deficient testes, suggesting that VRK1-deficient Sertoli
cells retain their ability to secrete important paracrine factors [17].
To prove that VRK1 is an intrinsic factor for the maintenance of
undifferentiated spermatogonia, repopulation assays using trans-
plantation of VRK1-deficient germ cell are needed.
Overall, our present study showed that the proliferative
capability of undifferentiated spermatogonia, including spermato-
gonial stem cells, is compromised at an early postnatal age by
VRK1-deficiency. Furthermore, in view of the specific biochem-
ical role of VRK1 in the progression of the cell cycle, these data
implicate VRK1 in the mitotic regulation of spermatogonial stem
cell maintenance. To elucidate the molecular mechanisms of
VRK1 in male germ cells, further investigation is expected to
clarify this important issue.
Materials and Methods
Ethics Statement
Approval of the study protocol was obtained from the Pohang
University of Science and Technology Institutional Animal Care
and Use Committee (approval ID: LIFE 012). All animal
experiments carried out according to the provisions of the Animal
Welfare Act, PHS Animal Welfare Policy, and the principles of the
NIH Guide for the Care and Use of Laboratory Animals. All mouse
lines weremaintainedunder specific pathogen-free conditions at the
POSTECH animal facility under institutional guidelines.
Mice
The gene-trapped ES cell line RRR178 was obtained from
BayGenomics. This cell line was generated using a gene trap
protocol with the pGT1lxf construct, which contains the intron
from engrailed 2 upstream of a gene encoding b-galactosidase/
neomycin resistance, b-geo (see http://www.genetrap.org). The ES
cell clone was injected into a C57BL/6 blastocyst according to
standard procedures. Male chimeras were bred with C57BL/6
mice to create animals with a germ-line transmission of the mutant
allele. Heterozygous mice were backcrossed a minimum of six
generations with C57BL/6 mice prior to the study. Genotyping
was performed by PCR and Southern blot using DNA extracted
from mouse tails. Insertion of the b-geo cassette was verified by
PCR (b-geo primer sense, 59-ATCGCAGATCTGGACTCTA-
GAGGATCC-39 and antisense, 59-ATGCGCTCAGGTCAA-
ATTCAGACGGCAA-39 and Int4 primer sense, 59-ATCGCA-
GATCTGGACTCTAGAGGATCC-39 and antisense, 59-GGA-
GAAACTTTGTACAGCTTCGTT-39,5 9-AAGGAATCTTGG-
TTAGCTTTCAGA-39).
Preparation of the anti-mouse VRK1 antibody
Mouse VRK1 antisera were generated in rabbits using
recombinant mouse VRK1 (accession number NM_011705.3) as
the immunogen. Approximately 1 mg recombinant mouse VRK1
was used to immunize rabbits with complete Freund’s adjuvant by
subcutaneous injection. Two weeks after the first immunization,
the rabbits were boosted with incomplete adjuvant. Rabbits were
boosted once more with only recombinant protein weeks after the
second immunization. Rabbit serum was collected and subjected
to affinity purification using a HiTrap Protein G column (GE
Healthcare).
Histology and b-gal histochemistry
For histological analyses, testes were fixed in cold 4%
paraformaldehyde, processed into paraffin sections, and stained
with hematoxylin and eosin. Histochemical analysis of b-
galactosidase reporter activity was performed with frozen sections
following the standard method.
In situ hybridization
A 349-base pair fragment of VRK1 cDNA was obtained by RT-
PCR with the use of the oligonucleotides VRK1-349 (f), 59-
TGGAAAAAGTTACAGGTTTATGATAATG -39, and VRK1-
349 (r), 59-GTAGTTTCACAGACTCCATGTACTTAGC-39.
Synthesis of both anti-sense and sense probes was performed
followed by cloning into the pGEM-easy vector. Cryostat sections
were hybridized with probes labeled with digoxygenin. Samples
were incubated with anti-DIG POD antibody (Roche) and
detected using Cy3 Tyramide Signal Amplification (TSA,
PerkinElmer, Waltham, MA).
Immunohistochemistry and immunocytochemistry
Sorted cells were attached to a poly-D-lysine glass slide for
immunocytochemistry and then stained with antibodies against
VRK1 and Oct4 (sc-5279, Santa Cruz Biotechnology, Santa Cruz,
CA) or Plzf (OP128, Calbiochem, San Diego, CA). For immunohis-
tochemistry, testes were fixed in 4% paraformaldehyde, dehydrated
using an ethanol series, and embedded in paraffin. Sectioned tissues
(5 mm) were dehydrated and stained with antibodies.
Flow Cytometry
To analyze undifferentiated spermatogonial cell populations,
spermatogonial cell populations were enriched using magnetic-
activated cell sorting (MACS) (Miltenyi Biotech, Bergisch
Gladbach, Germany). Dissociated testicular cells (1610
7) were
incubated with anti-Ep-CAM antibody followed by anti-rat IgG
secondary antibody conjugated to microbeads. Ep-CAM
+ cells
were resuspended in PBS containing 1% FBS and then stained
with APC-conjugated anti-c-kit, R-phycoerythrin (PE)-conjugated
anti-a6-integrin, and biotin-conjugated anti-Thy-1.2 antibodies
prior to flow cytometry analysis. PerCP-conjugated streptavidin
was used as a second step to detect Thy-1.2. To identify VRK1
expression, Ep-CAM positive and negative cells were labeled with
fluorescein di-D-galactopyranoside (FDG; Invitrogen) per the
manufacturer’s protocol. For the staining with FDG, stock solution
(20 mM) was diluted 1:10 with DW and prewarmed at 37uC. This
solution was mixed with same volume of PBS and incubated with
cells for 1 min at 37uC. After incubation, cells were washed with
1 ml of cold PBS. Cells were further stained with (PE)-conjugated
anti-a6-integrin antibody for identifying undifferentiated sper-
matogonial population. All antibodies were purchased from BD
Biosciences (San Jose, CA). Flow cytometry was performed on a
FACSCalibur (BD Biosciences).
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Total RNA samples from day8 wild type and VRK1-deficient
mice (n=4, each) were prepared from intact testicular cells using
Trizol (Invitrogen, Carlsbad, CA) and then reverse transcribed
using the ImProm-II Reverse Transcription System (Promega).
Quantitative PCR was performed on a MyIQ single time, real-
time detector system (Bio-Rad, Hercules, CA) using the SYBR
Green PCR mixture (TAKARA BIO INC.) as described
previously [37]. b-actin expression was used to normalize
transcript levels. Relative values of transcripts were derived using
the equation, 2
2DDCt, where DCt is equal to the difference in
threshold cycles. PCR primer sequences are listed in supplemental
Table S2. Error bars were calculated as the range in fold change of
VRK1-deficient transcript levels (mean 6 standard deviation)
relative to the mean of wild type transcript.
Whole-mount immunofluorescence staining
Testes were removed from their capsules and placed in cold
PBS. Tubules were dissociated from each other and removed from
interstitial material with 1 mg/ml collagenase IV. After fixation in
PBS containing 4% paraformaldehyde, the samples were incubat-
ed in blocking solution. Spermatogonial stem cells were stained
with a Plzf antibody (Calbiochem, OP128) followed by staining
with an Alexa Fluor 488-conjugated goat anti-mouse antibody.
After washing in PBS, tubules were stained for 10 min with
Hoechst 33342 in PBS and mounted in Vectashield mounting
medium (Vector Laboratories, Burlingame, CA).
DNA microarray analysis
Global gene expression analysis was conducted using Agilent
Whole Genome Mouse Microarrays and One-Color Quick Amp
Labeling Kit (Agilent Technologies, Inc., Santa Clara, CA)
according to the manufacturer’s protocol. Briefly, 0.5 mg of total
RNA was reverse transcribed using T7 promoter primers and
MMLV reverse transcriptase. cRNA was amplified by T7 RNA
polymerase and labeled with Cy-3 dye, followed by column
purification provided in the RNeasy Mini Kit (Qiagen, Inc.,
Chatsworth, CA). Labeled samples were hybridized with probes
on the microarrays at 65uC for 17 hours, and the microarrays
were scanned using an Agilent Microarray Scanner after washing
out unbound samples. Microarray expression data were extracted
and analyzed using the Agilent Feature Extraction Software and
GeneSpring GX respectively. Fold changes were calculated as a
ratio between signal averages of four biological replicates of wild
type and VRK1-deficient mice with statistical significance given by
the Student’s t-test (cutoff p-value=0.05), and these significantly
changed genes were used for gene ontology analysis. The raw data
have been deposited in NCBI’s Gene Expression Omnibus and are
accessible through GEO Series accession number GSE22674.
Supporting Information
Figure S1 Characterization of VRK1-deficient mice. (A)
Schematic representation of the wild type and mutant (VRK1-
deficient) gene locus of VRK1. The insertion site, corresponding
coding exons (light gray) and noncoding exons (open box), and the
b-geo cassette (yellow) are shown. Thin (noncoding) and thick
(coding sequences) lines under exons represent the expected
transcripts derived from the wild type and VRK1-deficient alleles.
b-geo indicates the bacterial b-galactosidase fused to the neomycin
resistance gene. Primers for genotyping are represented by arrows.
Red box indicates the region for the Southern blot probe. (B) PCR
analysis of genomic DNA (gDNA) isolated from three littermates
produced by heterozygotes crosses. (Upper panel) PCR product
amplified with Int4 primers showing a 600-bp band from gDNA of
wild type and heterozygote mice. (Lower panel) PCR product
amplified with b-geo primers showing a 550-bp band from gDNA
of wild type and VRK1-deficient mice. (C) Southern blot analysis
of genomic DNA. Probing of BamHI-digested DNA revealed 7.5-
kb and 5.5-kb fragments for the wild type and VRK1-deficient
alleles, respectively. (D) mRNA levels of VRK1 in different tissues
harvested from wild type and VRK1-deficient mice. Semi-
quantitative PCR was performed with primers that amplify Exon2
to Exon4. b-actin was used as a loading control.
(TIF)
Figure S2 The validation of mouse VRK1 antibody. (A)
Immunoblot of endogenous mouse VRK1 in spleen and
recombinant mouse VRK1 protein with anti-mVRK1 antibody.
(B) Expression pattern of VRK1 in wild type and VRK1-deficient
mouse organs. Lamin B was used as a loading control.
(TIF)
Figure S3 Loss of undifferentiated spermatogonia in
VRK1-deficient testes. nine-week-old testes of wild-type and
VRK1-deficient mice were examined by whole-mount immuno-
staining with anti-Plzf antibody. Scale bars, 10 mm.
(TIF)
Table S1 Gene ontology terms of the genes with a significant
change in the expression level in VRK1-deficient mice.
(TIF)
Table S2 Primers for qRT-PCR.
(TIF)
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